Back

Stability of SARS-CoV-2 spike antigens against mutations

Martinez De la Fuente, I.; Malaina, I.; Fedetz, M.; Chruszcz, M.; Grandes, G.; Targoni, O.; Lozano-Perez, A. A.; Shteyer, E.; Ben Ya'akov, A.; Gomez de la Camara, A.; M. Borobia, A.; Carrasco-Pujante, J.; Ignacio Pijoan, J.; Bringas, C.; Perez-Yarza, G.; Ouro, A.; Crawford, M. J.; Shoshan-Barmatz, V.; Zhurov, V.; Lopez, J. I.; Knafo, S.; Tary-Lehmann, M.; Gabaldon, T.; Grbic, M.

2022-10-15 epidemiology
10.1101/2022.10.13.22280980 medRxiv
Show abstract

We have developed a computational method "Multi-Stable Epitope Sequencer" to predict mutation-resistant regions with stability against future viral variability. At the beginning of the pandemic, this approach allowed us to identify a set of eight SARS-CoV-2 spike protein sequences that had the potential to be mutationally stable. We have tested this methodology on the SARS-CoV-2 viral linages that occurred throughout the COVID-19 pandemic. These eight peptide sequences (epitopes) have been preserved in 97% of all SARS-CoV-2 lineages reported in the CoV-GLUE dataset during the pandemic period. Likewise, more than 90% of these peptides remained invariable across the 49 predominant viral variants circulating throughout the pandemic (ECDC-WHO). In addition, the eight selected peptides were preserved in 94.1% of all 28 variants considered of most interest in the CoV-GLUE project. Our analyses confirm the predicted mutational stability of the eight selected short viral peptides over the entire COVID-19 pandemic.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.